ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Sjogren’s syndrome"

  • Abstract Number: 1069 • 2017 ACR/ARHP Annual Meeting

    Significantly Elevated Serum Protein-Adduction with 4-Hydroxy-2-Nonenal but Not Malondialdehyde in Sjogren’s Syndrome

    Biji T Kurien1,2,3, Sona Nuguri4, Bre'ana Byrd5, Joey Maher6, Rohit Thomas4, Huyen Tran7 and R. Hal Scofield8, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2U.S. Department of Veterans Affairs Medical Center, Oklahoma City, OK, 3College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Oklahoma School of Science and Mathematics, Oklahoma City, OK, 5University of Central Oklahoma, Edmond, OK, 6University of Oklahoma, Norman, OK, 7University of Oklahoma Health Sciences Center, Edmond, OK, 8Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is a chronic inflammatory, autoimmune disorder characterized by diminished lacrimal and salivary gland secretion resulting in keratoconjunctivitis sicca and xerostomia. Autoantibodies,…
  • Abstract Number: 1795 • 2017 ACR/ARHP Annual Meeting

    IL-7 in Primary Sjogren Syndrome (pSS) Is Secreted By Salivary Gland Epithelial Cells after IFN Stimulation and Is Associated with B-Cell Activation

    Alexandre Virone1, Juliette Pascaud2, Elodie Rivière1, Jacques-Eric Gottenberg3, Véronique Le Guern4, Xavier Mariette1 and Gaetane Nocturne5, 1Université Paris Sud, Paris, France, 2U1184 IMVA, Université Paris Sud, Le Kremlin-Bicêtre Cedex, France, 3CNRS, Immunopathologie et Chimie Thérapeutique/Laboratory of Excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France, 4Internal Medicine Department, Cochin Hospital, “René-Descartes Paris V” University, Paris, France, 5INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicêtre, France

    Background/Purpose : pSS is characterized by a strong IFN signature, ectopic germinal centers formation and a chronic blood lymphopenia. IL-7 plays a central part in…
  • Abstract Number: 565 • 2017 ACR/ARHP Annual Meeting

    Fatigue in Primary Sjögren’s Syndrome (pSS) Is Associated with Lower Levels of Proinflammatory Cytokines: A Validation Study

    Kristen Davies1, Kamran Mirza1, Jessica Tarn2, Nadia Howard Tripp3, Robert J. Moots4, Nagui Gendi5, Michele Bombardieri6, Costantino Pitzalis6, Nurhan Sutcliffe6, Simon Bowman7, Neil J. McHugh8, John McLaren9, Devesh Mewar10, David Coady11, Kirsten MacKay12, Susan Knight13, Monica Gupta14, Marian Regan15, Cathy Lawson16, Jacqueline Andrews17, Peter Lanyon18, Mohammed Akil19, Elizabeth Price20, Annie Cooper21, Frances Hall22, Theodoros Dimitroulas23, Gavin Clunie24, Saravanan Vadivelu25, Ian Giles26, Bhaskar Dasgupta27, Steve Young-Min28, Dennis Lendrem29,30 and Wan-Fai Ng2,31, 1Institute of Cellular Medicine, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom, 3Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 4University of Liverpool, Liverpool, UK, Liverpool, United Kingdom, 5Basildon and Thurrock University Hospital, Basildon, UK, Basildon, United Kingdom, 6Barts Health NHS Trust & Barts and the London School of Medicine & Dentistry, London, UK, London, United Kingdom, 7Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, Birmingham, United Kingdom, 8Royal National Hospital for Rheumatic Diseases, Bath, UK, Bath, United Kingdom, 9NHS Fife, Kirkcaldy, UK, Kirkcaldy, United Kingdom, 10Royal Liverpool University Hospital, Liverpool, UK, Liverpool, United Kingdom, 11Sunderland Royal Hospital, Sunderland, UK, Sunderland, United Kingdom, 12Torbay Hospital, Torquay, UK, Torquay, United Kingdom, 13Macclesfield General Hospital, Macclesfield, UK, macclesfield, United Kingdom, 14Gartnavel General Hospital, Glasgow, UK, Glasgow, United Kingdom, 15Royal Derby Hospital, Derby, UK, Derby, United Kingdom, 16Harrogate District Hospital, Harrogate, UK, Harrogate, United Kingdom, 17Leeds Teaching Hospitals NHS Trust, Leeds, UK, Leeds, United Kingdom, 18Nottingham University Hospitals NHS Trust, Nottingham, UK, Nottingham, United Kingdom, 19Royal Hallamshire Hospital, Sheffield, UK, Sheffield, United Kingdom, 20Great Western Hospital, Swindon, UK, Swindon, United Kingdom, 21Royal Hampshire County Hospital, Winchester, UK, Winchester, United Kingdom, 22Addenbrooke’s Hospital, Cambridge, UK, Cambridge, United Kingdom, 23Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK, Dudley, United Kingdom, 24Ipswich Hospital NHS Trust, Ipswich, UK, Ipswich, United Kingdom, 25Queen Elizabeth Hospital, Gateshead, UK, Gateshead, United Kingdom, 26Centre for Rheumatology, University College London, Centre for Rheumatology, University College London, UK, London, United Kingdom, 27Rheumatology, Southend University Hospital NHS Foundation Trust, Southend, UK, Westcliff-on-Sea, United Kingdom, 28Queen Alexander Hospital, Portsmouth, UK, Portsmouth, United Kingdom, 29Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle, United Kingdom, 30Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UK, Newcastle-upon-Tyne, United Kingdom, 31Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK, Newcastle-Upon-Tyne, United Kingdom

    Background/Purpose: Primary Sjögren’s syndrome (pSS) is a chronic autoimmune rheumatic disease causing various symptoms including dryness, fatigue and pain. Previous work by our group has…
  • Abstract Number: 1479 • 2017 ACR/ARHP Annual Meeting

    Difference in Clinical Presentation between Female and Male Patients with Primary Sjogren’s Syndrome at Diagnosis and in Long-Term Follow-up

    Jorge Ramírez1, Marika Kvarnstrom2, Susanna Brauner3, Chiara Baldini4, Per Eriksson5, Thomas Mandl6, Katrine Brække Norheim7, Svein Joar Johnsen8, Daniel S. Hammenfors9,10, Malin V. Jonsson11, Kathrine Skarstein12,13, Johan G. Brun9,10, Lars Rönnblom14, Helena Forsblad D’Elia15, Sara Magnusson Bucher16, Elke Theander17, Roald Omdal8, Roland Jonsson9,10, Gunnel Nordmark18 and Marie Wahren-Herlenius19, 1Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Solna, Sweden, 2Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 3Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 4Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 5Division of Rheumatology, Department of Clinical Experimental Medicine, Linköping University, Linköping, Sweden, Linköping, Sweden, 6Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, Lund, Sweden, 7Department of Internal Medicine, Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, Stavanger, Norway, 8Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, Stavanger, Norway, 9Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, Bergen, Norway, 10Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, Bergen, Norway, 11Section for Oral and Maxillofacial Radiology, Department of Clinical Dentistry, University of Bergen, Bergen, Norway, Bergen, Norway, 12Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, 13Department of Pathology, Haukeland University Hospital, Bergen, Bergen, Norway, 14Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden, Uppsala, Sweden, 15Department of Public Health and Clinical Medicine, Rheumatology, Umeå University, Umeå, Sweden., Umeå, Sweden, 16Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden, Örebro, Sweden, 17Department of Rheumatology, Skåne University Hospital, Malmö, Sweden, Malmö, Sweden, 18Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden, Uppsala, Sweden, 19Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: Despite men being less prone to develop autoimmune diseases, male sex has been associated with a more severe disease course in several systemic autoimmune…
  • Abstract Number: 2022 • 2017 ACR/ARHP Annual Meeting

    Diagnostic and Prognostic VALUE of Salivary GLAND Ultrasonography in Primary Sjögren’s Syndrome:  a Preliminary Study

    Maria Pascual1, Mercè López1, Joan Miquel Nolla2, Javier Narváez3, helena borrell1 and Carmen Moragues4, 1DEPARMENT OF RHEUMATOLOGY, HOSPITAL UNIVERSITARI DE BELLVITGE, BARCELONA, Spain, 2Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 3Rheumatology Department, Hospital de Bellvitge. Barcelona. Spain, L’Hospitalet de Llobregat, Spain, 4DEPARMENT OF RHEUMATOLOGY, HOSPITAL UNIVERSITARI DE BELLVITGE, barc+, Spain

    Background/Purpose: In recent years, salivary gland ultrasonography (SGUS) has emerged as a promising tool for the diagnosis and prognostic stratification of patiens with primary Sjögren’s…
  • Abstract Number: 566 • 2017 ACR/ARHP Annual Meeting

    Immune Response to Seasonal Flu Vaccination in Patients with Primary Sjogren’s Syndrome

    Albin Björk1, Marika Kvarnström2, Gudny Ella Thorlacius2 and Marie Wahren-Herlenius2, 1Department of Medicine, Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 2Unit of Experimental Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden

    Background/Purpose: Vaccination of rheumatic patients has been reported to induce lower antibody titers than in healthy individuals. However, studies have primarily included patients treated with…
  • Abstract Number: 1480 • 2017 ACR/ARHP Annual Meeting

    Risk of Ischemic Stroke in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis

    Jirapat Teerakanok1, Daniel Cordoba2, Sakolwan Suchartlikitwong3 and Kenneth Nugent4, 1Internal medicine, Texas Tech University health and sciences center, Lubbock, TX, 2Internal Medicine, Texas Tech University Health and Sciences Center, Lubbock, TX, 3Internal medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 4Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose: Primary Sjögren’s syndrome (SS) is an autoimmune disease of the exocrine glands with lymphocytic infiltration into lacrimal and salivary glands. Autoimmune diseases increase cardiovascular…
  • Abstract Number: 2123 • 2017 ACR/ARHP Annual Meeting

    Protein-Losing Enteropathy in Patients with Systemic Autoimmune Diseases: Characterization of 263 Cases (GEAS-SEMI Spanish Cohort)

    Alejandra Flores-Chavez1,2,3, Soledad Retamozo4,5,6, Angel Robles7, Guadalupe Fraile Rodriguez8, Sofia Arteaga9,10, Celeste Galceran-Chaves11, Roberto Pérez-Alvarez12, Marta Pérez de Lis12, Belchin Kostov13, Manuel Ramos-Casals14,15 and Pilar Brito-Zerón14,16, 1Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Spain., Barcelona, Spain, 2Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 3Programa de Doctorado en Ciencias Médicas, Centro Universitario de Investigaciones Biomédicas (CUIB), Universidad de Colima, Colima, Mexico, Mexico, Mexico, 4Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Córdoba, Consejo Nacional de Investigaciones Científicas y Técnicas (INICSA-UNC-CONICET), Cordoba, Argentina, 5Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Barcelona, Spain, 6Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, 7Department of Internal Medicine, Hospital La Paz, Madrid, Madrid, Spain, 8Internal Medicine, Hospital Ramón y Cajal, Madrid, Madrid, Spain, 9Department of Autoimmune Diseases, ICMiD, Hospital Clínic Barcelona, Barcelona, Spain, 10Universidad de Antioquía, Medellín, Colombia, Medellin, Colombia, 11Neuroscience Clinical Institute, Hospital Clínic, Barcelona, Barcelona, Spain, 12Department of Internal Medicine, Hospital Alvaro Cunqueiro, Vigo, Vigo, Spain, 13Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, CAPSE, Barcelona, Barcelona, Spain, 14Laboratory of Systemic Autoimmune Diseases “Josep Font”, CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Systemic Autoimmune Diseases, ICMID, Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 15Department of Medicine, University of Barcelona, Barcelona, Spain., Barcelona, Spain, 16Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona., Bacelona, Spain

    Background/Purpose: Protein-losing enteropathy (PLE) is a rare condition characterized by a loss of serum protein into the gastrointestinal tract resulting in hypoproteinemia, which can be…
  • Abstract Number: 569 • 2017 ACR/ARHP Annual Meeting

    Is the Oral Microbiome Involved in the Pathogenesis of Sjogren’s Syndrome?

    Taco A van der Meulen1, Frans G.M. Kroese2, S.C. Liefers2, Arnau Vich Vila3, Hermie J.M. Harmsen4, Hendrika Bootsma2, Fred K.L. Spijkervet1 and Arjan Vissink5, 1Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Gastroenterology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 4Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Environmental factors involved in the pathogenesis of primary Sjögren’s syndrome (pSS) are still largely unknown. The oral cavity is the microbial habitat closest to…
  • Abstract Number: 1481 • 2017 ACR/ARHP Annual Meeting

    Risk of Ischemic Heart Disease in Sjögren’s Syndrome Patients: A Systematic Review and Meta-Analysis of Observational Studies

    Jirapat Teerakanok1, Sakolwan Suchartlikitwong2, Thammasak Mingbunjerdsuk3, Praveen Ratanasrimetha3, Yuttiwat Vorakunthada3 and John S. Pixley3, 1Internal medicine, Texas Tech University health and sciences center, Lubbock, TX, 2Internal medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 3Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose: Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are associated with an increased risk of ischemic heart disease (IHD). The risk of IHD in…
  • Abstract Number: 2703 • 2017 ACR/ARHP Annual Meeting

    Single Cell Analysis of TCRs from CD8+ T Cells in Sjogren’s Syndrome

    Michelle L. Joachims1, Christina Lawrence1, Richard C. Pelikan1, Kerry M. Leehan1, Lida Radfar2, David M. Lewis3, Astrid Rasmussen1, R. Hal Scofield1, Kiely Grundahl1, Kathy L. Sivils1, Linda F. Thompson1 and A. Darise Farris1, 1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 3Department of Oral Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK

    Background/Purpose: Sjögren’s syndrome (SS) is an autoimmune exocrinopathy characterized by focal lymphocytic infiltration of the salivary and lacrimal glands, severe dry eyes and mouth, fatigue…
  • Abstract Number: 570 • 2017 ACR/ARHP Annual Meeting

    Signalling Pathways Identified in Salivary Glands from Primary Sjögren’s Syndrome Patients Reveal Enhanced Adipose Tissue Development, As Demonstrated By Microarray Analysis, Real-Time PCR and Immunohistochemistry

    Lara A Aqrawi1, Janicke C Liaaen Jensen1, Gunnvor Øijordsbakken2, Ann-Kristin Ruus3, Ståle Nygård4,5, Marit Holden6, Roland Jonsson7,8, Hilde Kanli Galtung9 and Kathrine Skarstein10,11, 1Department of Oral Surgery and Oral Medicine, University of Oslo, Oslo, Norway, 2Department of Clinical Medicine, University of Bergen, Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, 3Department of Oral Biology, University of Oslo, Oslo, Norway, 4Department of Informatics, University of Oslo, Oslo, Norway, 5Bioinformatics core facility, Institute for Cancer research, Oslo University Hospital, Oslo, Norway, 6Norwegian Computing Center, Oslo, Oslo, Norway, 7Broegelmann Research laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 8Department of Rheumatology, Haukeland University Hospital, Bergen, Bergen, Norway, 9Department of Oral Biology, University of Oslo, Oslo, Pakistan, 10Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway, 11Department of Pathology, Haukeland University Hospital, Bergen, Bergen, Norway

    Background/Purpose: : A characteristic feature of Sjögren’s syndrome (SS) is the destruction of salivary and lacrimal glands mediated by mononuclear cell infiltration. Adipocytes can also…
  • Abstract Number: 1482 • 2017 ACR/ARHP Annual Meeting

    Preliminary Population-Based Incidence and Prevalence Estimates of Primary Sjogren’s Syndrome from the Manhattan Lupus Surveillance Program

    Peter M. Izmirly1, Isabella Wan2, Sara Sahl3, Jill P. Buyon4, H. Michael Belmont5, Jane E. Salmon6, Anca Askanase7, Joan Bathon8, Laura Geraldino-Pardilla7, Yousaf Ali9, Ellen M. Ginzler10, Chaim Putterman11, Caroline Gordon12, Charles G. Helmick13 and Hilary Parton14, 1Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 2Medicine/Rheumatology, New York University School of Medicine, New York, NY, 3Pediatrics, Harbor-University of California at Los Angeles Medical Center, Torrance, CA, 4Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 5Medicine, New York University School of Medicine, New York, NY, 6Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 7Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 8Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 9Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 10Rheumatology, Division of Rheumatology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, 11Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA, Bronx, NY, 12Rheumatology Research Group, Institute of Inflammation and Ageing,, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 13Centers for Disease Control and Prevention, Atlanta, GA, 14Bureau of Epidemiology Services, New York City Department of Health and Mental Hygiene, Long Island City, NY

    Background/Purpose: The extant epidemiologic data of Primary Sjögren’s Syndrome (pSS) remains limited with few published estimates for the general population and little data regarding racial/ethnic…
  • Abstract Number: 2706 • 2017 ACR/ARHP Annual Meeting

    T Follicular-Helper CELLS (TFH) Enrichment and  T Follicular-Regulatory CELLS (TFR) Exclusion from Ectopic Germinal Centers in Salivary Glands of Sjogren’s Syndrome Patients

    Elena Pontarini1, William Murray Brown2, Cristina Croia2, Elisa Corsiero3, Davide Lucchesi2, Elisa Astorri2, Nurhan Sutcliffe2, Anwar Tappuni2, Costantino Pitzalis4 and Michele Bombardieri5, 1William Harvey Research Institute, London, United Kingdom, 2Queen Mary University of London, London, United Kingdom, 3Centre for Experimental Medicine & Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom, 4Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 5Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom

    Background/Purpose: Lymphocytic aggregates in the salivary glands (SG) of Sjögren’s syndrome (SS) can organize in ectopic lymphoid structures (ELS) forming functional germinal centers (GCs), which…
  • Abstract Number: 572 • 2017 ACR/ARHP Annual Meeting

    Biopsy Accuracy in Sjögren’s Syndrome: Analysis of  803 Patients Presenting with Sicca Syndrome Referred to Labial Salivary Gland Biopsy

    Diego Baenas1, Soledad Retamozo2, Juan Pablo Pirola3, Nadia Benzaquén4, María Flavia Ceballos5, Soledad Fiorentino3, Maria Jezabel Haye Salinas4, Nadia Riscanevo6, Janet Flores7, Ana C. Alvarez4, Verónica Saurit8, Alejandro Alvarellos8 and Francisco Caeiro9, 1Reumatologia, Hospital Privado Universitario de Córdoba, Córdoba, Argentina, 2Rheumatology Unit, Hospital Privado Universitario de Córdoba, Institute University of Biomedical Sciences University of Córdoba (IUCBC), Cordoba, Argentina, 3Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba., Cordoba, Argentina, 4Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Córdoba, Argentina, 5Rheumatology, Rheumatology Unit, Hospital privado Universitario de Córdoba., Cordoba, Argentina, 6Rheumatology, Rheumatology Unit, Hospital privado Universitario de Córdoba, Cordoba, Argentina, 7Rheumatology Unit, Hospital privado Universitario de Córdoba, Cordoba, Argentina, 8Rheumatology, Rheumatology Unit, Hospital Privado Universitario de Córdoba, Cordoba, Argentina, 9Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina

    Background/Purpose: Labial salivary gland biopsy (LSGB) is a minimally invasive procedure used in the diagnostic of Sjögren's Syndrome (SS). Objectives: to describe demographic, clinical and…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 26
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology